Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 2
2015 3
2016 6
2017 6
2018 11
2019 10
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
de Mel S, Hue SS, Jeyasekharan AD, Chng WJ, Ng SB. de Mel S, et al. J Hematol Oncol. 2019 Apr 2;12(1):33. doi: 10.1186/s13045-019-0716-7. J Hematol Oncol. 2019. PMID: 30935402 Free PMC article. Review.
Immunotherapy in Multiple Myeloma.
Soekojo CY, Ooi M, de Mel S, Chng WJ. Soekojo CY, et al. Among authors: de mel s. Cells. 2020 Mar 3;9(3):601. doi: 10.3390/cells9030601. Cells. 2020. PMID: 32138182 Free PMC article. Review.
STAT3: A Promising Therapeutic Target in Multiple Myeloma.
Chong PSY, Chng WJ, de Mel S. Chong PSY, et al. Among authors: de mel s. Cancers (Basel). 2019 May 26;11(5):731. doi: 10.3390/cancers11050731. Cancers (Basel). 2019. PMID: 31130718 Free PMC article. Review.
Risk Stratification in Multiple Myeloma.
Ooi MG, de Mel S, Chng WJ. Ooi MG, et al. Among authors: de mel s. Curr Hematol Malig Rep. 2016 Apr;11(2):137-47. doi: 10.1007/s11899-016-0307-4. Curr Hematol Malig Rep. 2016. PMID: 26883334 Review.
Potential Clinical Application of Genomics in Multiple Myeloma.
Soekojo CY, de Mel S, Ooi M, Yan B, Chng WJ. Soekojo CY, et al. Among authors: de mel s. Int J Mol Sci. 2018 Jun 10;19(6):1721. doi: 10.3390/ijms19061721. Int J Mol Sci. 2018. PMID: 29890777 Free PMC article. Review.
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.
Chan EHL, Koh LP, Lee J, De Mel S, Jeyasekharan A, Liu X, Tang T, Lim ST, Tao M, Quek R, Farid Bin Harunal Ras M, Lee YS, Diong C, Tan D, Kim SJ, Chee YL, Poon LMM. Chan EHL, et al. Among authors: de mel s. Cancer Med. 2019 Aug;8(10):4626-4632. doi: 10.1002/cam4.2347. Epub 2019 Jul 2. Cancer Med. 2019. PMID: 31264808 Free PMC article.
Immunoglobulin M Paraproteinaemias.
Girard LP, Soekojo CY, Ooi M, Poon LM, Chng WJ, de Mel S. Girard LP, et al. Among authors: de mel s. Cancers (Basel). 2020 Jun 25;12(6):1688. doi: 10.3390/cancers12061688. Cancers (Basel). 2020. PMID: 32630470 Free PMC article. Review.
Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders.
de Mel S, Tan JZ, Jeyasekharan AD, Chng WJ, Ng SB. de Mel S, et al. Front Pediatr. 2019 Jan 17;6:405. doi: 10.3389/fped.2018.00405. eCollection 2018. Front Pediatr. 2019. PMID: 30705877 Free PMC article. Review.
Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
Yip CYC, Yap ES, De Mel S, Teo WZY, Lee CT, Kan S, Lee MCC, Loh WNH, Lim EL, Lee SY. Yip CYC, et al. Among authors: de mel s. Br J Haematol. 2020 Jul;190(1):33-36. doi: 10.1111/bjh.16847. Epub 2020 Jun 2. Br J Haematol. 2020. PMID: 32420610 Free PMC article. Clinical Trial. No abstract available.
Implications of heterogeneity in multiple myeloma.
de Mel S, Lim SH, Tung ML, Chng WJ. de Mel S, et al. Biomed Res Int. 2014;2014:232546. doi: 10.1155/2014/232546. Epub 2014 Jul 2. Biomed Res Int. 2014. PMID: 25101266 Free PMC article. Review.
44 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback